In this study, we first showed inhibitory effect of atovaquone on colorectal cancer metastasis and that atovaquone inhibited tumour metastasis through the PDGFRβ/NF-κB/EMT signalling pathway. This evidence concerns the gene NFKB1 and colorectal cancer.